Neurocrine Biosciences Inc (NASDAQ:NBIX)

93.25
Delayed Data
As of May 18
 +0.76 / +0.82%
Today’s Change
41.76
Today|||52-Week Range
94.48
+20.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$8.2B

Company Description

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.

Contact Information

Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego California 92130
P:(858) 617-7600
Investor Relations:

Employees

Shareholders

Individual stakeholders8.68%
Mutual fund holders71.55%
Other institutional32.33%

Top Executives

Kevin Charles GormanChief Executive Officer & Director
Matthew C. AbernethyChief Financial Officer
Dimitri E. GrigoriadisChief Research Officer
Bill WilsonVice President-Information Technology & Operations
Eiry W. RobertsChief Medical Officer